Citations

Clear

4510 citation(s) found for "Scott, C".

Prevalence and prognostic role of atrial fibrillation in chronic severe aortic regurgitation
Pugliesi, Giordano Maria , Scott, Christopher G. , Nkomo, Vuyisile T. , Michelena, Héctor I. , Pislaru, Sorin V. , Kane, Garvan C. , Gillam, Linda D. , Pellikka, Patricia A. , Anand, Vidhu , Pugliesi, Giordano M , Sabbah, Michael S. , Nkomo, Vuyisile T , Scott, Christopher , Pellikka, Patricia A , Michelena, Hector I

Mayo Clinic

Heart | July 16, 2025 | Volume: 112 | Issue: 1 | Pages: 46-52

10.1136/heartjnl-2025-325823 | PMID 40670146 Get It

Background Atrial fibrillation (AF) impacts management decisions in valvular heart disease but its significance in patients with chronic aortic regurgitation (AR) is not well established. Objectives To evaluate the prevalence and prognostic role of AF in patients with chronic, haemodynamically significant AR. Methods Adults with chronic ≥moderate-to-severe AR, from March 2004 to April 2019, were retrospectively identified. Those with acute AR, moderate or worse other valve disease or prior valve surgery were excluded. Patients with AF were identified based on 12-lead ECGs, 1-lead ECGs (showing AF for ≥30 s), or episodes recorded by implanted cardiac devices. Primary outcome was all-cause mortality. Cox regression models were used to assess associations with mortality: model 1 adjusted for age, symptoms (New York Heart Association class II–IV), Charlson Comorbidity Index, left ventricle (LV) end-systolic volume index and AF; model 2 added left atrial volume index and model 3 further added systolic pulmonary artery pressure. Results Of the 1006 included patients (age 59±18 years; 822 (82%) men), 446 (46%) had hypertension and 364 (36%) had a bicuspid aortic valve. AF was present in 161 (16%) patients at the time of ≥moderate-to-severe AR diagnosis. During a median follow-up of 1.6 years (IQR 0.2–6.2), AF was associated with an increased mortality risk in univariate and in all three multivariable models (HR 1.61 (95% CI 1.07 to 2.43), HR 2.21 (95% CI 1.31 to 3.72) and HR 2.06 (95% CI 1.21 to 3.52), respectively), including after propensity matching (HR 1.58 (95% CI 1.01 to 2.48)). Conclusions AF is present in one in six patients with chronic≥moderate-to-severe AR and is associated with an increased risk of mortality even after adjusting for measures of LV systolic and diastolic function. There is a need for future prospective studies to validate these findings and evaluate AF as a potential trigger for early surgery.
A Cross-Sectional Analysis of Foot and Ankle Fellowship Match From 2012 to 2023: Does Gender or Degree Type Matter?
Havasy, Janice , Arciero, Emily , Choy, Kenneth, Cannada, Lisa K. , Steinmann, Scott P. , Cohn, Randy M. , Steinmann, Scott, Cohn, Randy , Bitterman, Adam D

Mayo Clinic

Foot & Ankle Orthopaedics | July 16, 2025 | Volume: 10 | Issue: 3 | Pages: No page available

10.1177/24730114251353224 | PMID 40678393 Get It

Background: In recent years, there has been an increased push for diversity in orthopaedics at the residency level. There has also been a noticeable shift away from foot and ankle fellowship, with many fellowship positions open throughout the country annually. With the increase in osteopathic and female orthopaedic applications to orthopaedic surgery residency, we hypothesized that this would be reflected in the foot and ankle fellowship applications in the last decade. Methods: The San Franscisco Match data from 2012 to 2023 were analyzed for degree type and from 2013 to 2023 for gender. There were 1082 applicants for adult foot and ankle fellowships from 2012 to 2023, 74 osteopathic applicants (11.4%), and 573 allopathic applicants (88.6%). There were 126 female applicants (21.3%) and 465 male applicants (78.7%). The 435 international graduates were excluded from this analysis. The degree type, gender, number of applicants, and number of applicants matched into orthopaedic foot and ankle fellowship was reviewed. Results: The number of osteopathic applicants and female applications did not change significantly over the study period. There was a statistically significant decrease in the number of allopathic applicants ( P = .003) and a significant decrease in the number of male applicants to foot and ankle fellowship ( P = .00004). The match rate for allopathic, osteopathic, and male applicants all statistically increased over the study periods, whereas the female applicant match rate remained stable. Programs tended to rank their matched allopathic residents higher, whereas osteopathic applicants’ position in the fellowship program rank list remained steady. Female and male applicants matched at programs higher on their rank lists, whereas programs match applicants lower on theirs. Conclusion: More orthopaedic foot and ankle surgeons are needed nationwide. Understanding recent trends in applicant demographics and match outcomes may help inform strategies to increase interest and participation in this subspecialty. Level of Evidence: IV, cross-sectional study.
Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report
Al‐Samkari, Hanny , Kasthuri, Raj S. , Mager, Hans‐Jurgen, Zhou, Jenny Y. , Serra, Marcelo M. , Samuelson‐Bannow, Bethany T., Doren, Layla N Van , Piccirillo, Jay F. , Clancy, Marianne S. , Thomas, Sonia , Riera‐Mestre, Antoni , Gossage, James R. , Hermans, Cédric , Hammill, Adrienne M. , Drygalski, Annette von , Olitsky, Scott E., Faughnan, Marie E. , Sewaralthahab, Sarah , Iyer, Vivek N , Al-Samkari, Hanny , Hammill, Adrienne , Kasthuri, Raj S , Thomas, Sonia M , McCrae, Keith R. , Pishko, Allyson M. , Iyer, Vivek , Winship, Ingrid , Mei‐Zahav, Meir

Mayo Clinic

American Journal of Hematology | July 15, 2025 | Volume: 100 | Issue: 10 | Pages: 1813-1827

10.1002/ajh.70011 | PMID 40662351 Get It

ABSTRACT Hereditary hemorrhagic telangiectasia (HHT, Osler‐Weber‐Rendu disease) is the second most common inherited bleeding disorder worldwide, affecting approximately 1 in 5000 people. Development of disease‐modifying and efficacious hemostatic agents to treat HHT has finally begun after decades without such medical therapies. However, the lack of consensus on standardized severity definitions, outcome criteria, and terminology remains a major obstacle to clinical investigation and therapeutic development in HHT. Additionally, with the ongoing repurposing of antiangiogenic agents and emerging development of novel HHT‐specific therapies, comparative clinical trials are expected in the future. Therefore, to end the problematic heterogeneity hindering these efforts, the Global Research and Medical Advisory Board (GRMAB) of the Cure HHT Foundation, an international group of recognized HHT experts, convened a conference of expert HHT clinician‐investigators from within GRMAB as well as invited external experts in HHT and bleeding disorders generally, patients with HHT, and patient advocates to define standard terminology and definitions for outcomes and severity classification for bleeding and anemia in HHT. These criteria and definitions should be adopted by regulators, investigators, and the pharmaceutical industry in the development and performance of interventional clinical trials and cohort studies to allow improved comparability between clinical trials, facilitate communication between clinicians and investigators, improve therapeutic guideline development, and provide a standardized framework for regulatory agencies. Search Strategy and Selection Criteria Evidence for this report was systematically identified and evaluated utilizing two search strategies in Ovid MEDLINE, described in full detail in the Appendix, pp.4–13. The searches were conducted on January 7, 2025. The titles and abstracts of each record were reviewed, and the inclusion criteria were applied to all search results to identify full text articles to be retrieved for further review. All retrieved full texts were then reviewed to reach a final determination if a study met the inclusion criteria. Included references were then compiled into evidence tables, which were then utilized by the International Consensus Report Working Group throughout the development of report recommendations.
In-Bore MRI-Guided Ureteral Stent Placement During Prostate Cancer Cryoablation—A Case Series
Whalen, Sydney, Woodrum, David A. , Adamo, Daniel A. , Lomas, Derek J. , Mynderse, Lance A. , Woodrum, David, Adamo, Dan , Lomas, Derek , Mynderse, Lance , Whalen, Sydney, Thompson, Scott M.

Mayo Clinic

Diagnostics | July 15, 2025 | Volume: 15 | Issue: 14 | Pages: 1781

10.3390/diagnostics15141781 | PMID 40722529 Get It

Introduction: Ureteral stents are widely used in the specialty of urology to preserve renal function and provide ureteral patency in cases of urolithiasis, strictures, malignancy, and trauma. This paper presents a novel application of prophylactic ureteral stents deployed under MRI-guidance for ureteral protection in the setting of in-bore salvage cryoablation therapy for recurrent and metastatic prostate cancer. This is the first known case series of ureteral stent placement using near real-time MRI. Materials and Methods: A retrospective chart review was performed for all patients who underwent MRI-guided ureteral stent placement prior to in-bore cryoablation therapy from 2021 to 2022. Each case was managed by an interdisciplinary team of urologists and interventional radiologists. Preoperative and postoperative data were collected for descriptive analysis. Physics safety testing was conducted on the cystoscope and viewing apparatus prior to its implementation for stent deployment. Results: A total of seven males, mean age 73.4 years (range 65–81), underwent successful prophylactic, cystoscopic MRI-guided ureteral stent placement prior to cryoablation therapy of their prostate cancer. No intraoperative complications occurred. A Grade 2 postoperative complication of pyelonephritis and gross hematuria following stent removal occurred in one case. The majority of patients were discharged the same day as their procedure. Conclusions: This case series demonstrates the feasibility of in-bore cystoscopic aided MRI guidance for ureteral stent placement. Ureteral stents can be used to increase the safety margin of complex cryoablation treatments close to the ureter. Furthermore, by following the meticulous MRI safety protocols established by MRI facility safety design guidelines, MRI conditional tools can aid therapy in the burgeoning interventional MRI space.
Subcutaneous Immunotherapies in Solid Tumors: Are We Truly Expanding Access and Efficiency?
Ibodeng, Gogo-ogute E. , Jensen, Chelsee , Soefje, Scott A. , Desai, Aakash , Ibodeng, Gogo-Ogute , Desai, Aakash P , Jensen, Chelsee J , Soefje, Scott A

Mayo Clinic

JCO Oncology Practice | July 14, 2025 | Volume: 22 | Issue: 2 | Pages: 181-184

10.1200/op-25-00052 | PMID 40658915 Get It

Association of Diuretic Dosage With Outcomes in Patients With Hemodynamically Significant Isolated Tricuspid Valve Regurgitation
Anand, Vidhu , Scott, Christopher G. , Ali, Khaled A., Nkomo, Vuyisile T. , Thaden, Jeremy J. , Kane, Garvan C. , Borgeson, Daniel D., Borlaug, Barry A. , Pislaru, Cristina , Eleid, Mackram F. , Ali, Khaled, Crestanello, Juan A , Pellikka, Patricia A , Sabbah, Michael S. , Nkomo, Vuyisile T , Scott, Christopher , Borlaug, Barry A , Pislaru, Cristina , Ali, Khaled, Crestanello, Juan A. , Pellikka, Patricia A. , Pislaru, Sorin V.

Mayo Clinic

Journal of the American Heart Association | July 14, 2025 | Volume: 14 | Issue: 14 | Pages: No page available

10.1161/jaha.124.039989 | PMID 40654247 Get It

Background Tricuspid valve surgery is recommended for severe isolated tricuspid regurgitation (TR) if symptoms persist despite optimal medical therapy. The definition of optimal therapy for TR is unclear beyond managing underlying conditions. Diuretics are the primary treatment for volume retention in TR, but it is unknown whether a “safe diuretic dose” exists for conservative management. We sought to evaluate the association between diuretic dose and outcomes. Methods Adult patients with ≥moderate–severe isolated TR were retrospectively identified from echocardiographic reports. Clinical and echocardiographic data were extracted from electronic medical records and manually reviewed. The primary end point was all‐cause mortality. Loop diuretic doses were converted to furosemide equivalent and categorized into 4 groups: <40 mg, 40 to 79 mg, 80 to 159 mg, and ≥160 mg daily. Results Of 1302 patients (age 72±13 years, 60% female), 565 (43%) had moderate–severe TR and 737 (57%) had severe TR. Median follow‐up was 8.7 (1.4, 14.0) years. Comorbidities increased with higher diuretic doses. A linear relationship between diuretic dose and mortality was observed in spline‐curve analysis. Hazard ratios (and CIs) for mortality adjusted for age, sex, coronary disease, chronic kidney disease, mild pulmonary hypertension, and New York Heart Association III/IV symptoms were 1.21 (0.96–1.53) ( P =0.12) for <40 mg, 1.50 (1.23–1.82) ( P <0.001) for 40 to 79 mg, 1.86 (1.46–2.37) ( P <0.001) for 80 to 159 mg, and 2.90 (2.18–3.88) ( P <0.001) for ≥160 mg furosemide equivalent. Any diuretic dose was associated with significant symptoms (New York Heart Association III–IV), with more patients experiencing symptoms at higher doses. Conclusion A daily loop diuretic dose ≥40 mg furosemide equivalent is associated with increased mortality and greater symptom severity in patients with TR.
An analysis of patient-reported outcomes among epidural steroid injection clinical trials
Khan, Adam , Ladd, Chase , Smith, Caleb J. , Douglas, A.G., Jacobsen, Sam, Otwell, Ryan, Pierce, Aaron, Relic, Aaron, Butler, Casey, Vassar, Matt, Roberts, Will , Douglas, Alexander, Jacobsen, Samuel M. , Hartwell, Micah L. , Khattab, Ahmad, Vassar, Matt B.

Mayo Clinic

Regional Anesthesia & Pain Medicine | July 14, 2025 | Volume: No volume available | Issue: No issue available | Pages: rapm-2025-106861

10.1136/rapm-2025-106861 | PMID 40659444 Get It

E-291 Magnetic capture of autologous mesenchymal stem cells promotes the rapid endothelialization of peripheral venous stents in rabbits
Oliver, A, Cortese, Jonathan, Ding, Yumei , Christensen, T. , Gamb, Scott I., Ranatunga, Wasantha , Carlson, K.D., Teffth, B, Kadirvel, R, Dragomir‐Daescu, Dan , Kallmes, D, Cortese, Jonathan , Dai, Daying , Bayraktar, E, Christensen, T, Hajj, G El , Ognard, Julien , Carlson, K, Pandey, M, Guillory, Roger J. , Kallmes, David F.

Mayo Clinic

SNIS 22nd annual meeting electronic poster abstracts | July 14, 2025 | Volume: No volume available | Issue: No issue available | Pages: A291.2-A292

10.1136/jnis-2025-snis.406 Get It

E-059 Influence of race on extended length of stay following mechanical thrombectomy for anterior circulation stroke
Koo, A, Johnson, Scott, Starke, R, Welch, Babu G. , Rivet, Dennis J. , Graffeo, Christopher S. , Klopfenstein, Jeffrey D., Sahlein, D, Eshraghi, Sheila, Altschul, D, Alaraj, A, Davies, Jason M., Raper, D, Park, M , Malek, Adel M. , Monteith, Stephen J., Eckardt, Glenn S., Beaty, N, Schirmer, C, Arthur, A, Wolfe, S, Chen, C, Church, E, Dornbos, D, Chu, T, Johnson, S, Starke, R, Altschul, David , Ringer, Andrew J. , Hoh, Brian L. , Alaraj, Ali , Mocco, J , Grande, Andrew Walker , Eckardt, G, Beaty, Narlin Bennet , Schirmer, Clemens M., Arthur, A, Dornbos, David

Mayo Clinic

SNIS 22nd annual meeting electronic poster abstracts | July 14, 2025 | Volume: No volume available | Issue: No issue available | Pages: A132.1-A132

10.1136/jnis-2025-snis.175 Get It

The Geriatric Emergency Care Applied Research Standardization Study ( GEARSS ): An Observational Study of Older Emergency Department Patients
Hwang, Ula , Sifnugel, Natalia, Cohen, Inessa , Han, Ling, Araujo, Katy, Bianco, Luann, Capelli, Sandra, Cruz, Daniel S. , Fishman, Ivy L., Gipson, Katrina, Hung, William W. , Kang, Raymond , Lockhart, Mechelle, Ohuabunwa, Ugochi , Ottilie‐Kovelman, Sierra, Partridge, Caitlin, Platts‐Mills, Timothy F. , Sandoval, Jacqueline , Taylor, Zachary , Tomasino, Debra F. , Vaughan, Camille P. , Tomasino, Debra F , Vaughan, Camille P , Hwang, Ula , Brandt, Cynthia , Carpenter, Christopher R. , Dresden, Scott M. , Hastings, Susan N. , Meeker, Daniella , Taylor, Zachary

Mayo Clinic

Academic Emergency Medicine | July 12, 2025 | Volume: 33 | Issue: 1 | Pages: No page available

10.1111/acem.70101 | PMID 40650481 Get It

ABSTRACT Objectives Multicenter research of geriatric emergency department (GED) care remains limited. Our objectives were to: 1. Prospectively collect data prioritized by the Geriatric Emergency care Applied Research (GEAR) network, a transdisciplinary taskforce for GED care, and create a multicenter GED research repository of prospective and electronic health record (EHR) data, 2. Assess concordance between prospective and EHR data. Methods The GEAR Standardization Study (GEARSS) is a multicenter, prospective study of older emergency department (ED) patients (65+) focusing on the 4Ms of age‐friendly care (mobility, medication safety, mentation, what matters) and elder mistreatment. Demographic and clinical data were collected via interviews by trained research assistants (RA) on Days 0, 4, 30, and 90 and linked to EHR. Prevalence of chronic comorbidities and incident delirium were measured and reported using descriptive statistics. Prospective and EHR data concordance was assessed with Cohen's Kappa. Results 999 participants were recruited from 5 EDs (3/25/2021–6/30/2022) across 3 institutions: Grady Health System, Northwestern Memorial Hospital, and Yale New Haven Health. The cohort was 57.0% female, 55.2% White, 39.1% Black, and 3.4% Hispanic, and the mean age was 75.1 years. For rheumatologic disease, peptic ulcer disease, diabetes, renal disease, and cancer, prevalence differed between prospective and EHR data by > 10%. About two‐thirds of participants were at risk for falls. Concordance between prospective and EHR data was good for ethnicity ( K = 0.73); excellent for sex ( K = 1.00), age ( K = 1.00), and race ( K = 0.98); fair for disposition ( K = 0.53); slight for ED observation status ( K = 0.33) and dementia diagnosis ( K = 0.24); poor for delirium presence ( K = 0.07). Conclusion In GEARSS, demographic variables aligned strongly between prospective and EHR data, while diagnosis, disposition, and mentation factors did not. This multicenter data source provides preliminary findings for common geriatric syndromes and conditions. Choice of measures using these data should be driven by GED research questions.